{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:47:01Z","timestamp":1792104421769,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s13760-020-01274-w","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T13:02:58Z","timestamp":1579611778000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Does retina play a role in Parkinson's Disease?"],"prefix":"10.1007","volume":"120","author":[{"given":"Subramaniam","family":"Mohana Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyer","family":"Mahalaxmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nair P.","family":"Aswathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Dhivya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-6839","authenticated-orcid":false,"given":"Vellingiri","family":"Balachandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132:1128\u20131145","journal-title":"Brain"},{"key":"1274_CR2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00702-009-0292-z","volume":"116","author":"I Bodis-Wollner","year":"2009","unstructured":"Bodis-Wollner I (2009) Retinopathy in Parkinson disease. J Neural Transm Suppl 116:1493\u20131501","journal-title":"J Neural Transm Suppl"},{"key":"1274_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.kjms.2017.11.006","volume":"34","author":"TS Aydin","year":"2018","unstructured":"Aydin TS, Umit D, Nur OM, Fatih U, Asena K, Nefse OY, Serpil Y (2018) Optical coherence tomography findings in Parkinson\u2019s disease. Kaohsiung J Med Sci 34:166\u2013171","journal-title":"Kaohsiung J Med Sci"},{"key":"1274_CR4","doi-asserted-by":"crossref","first-page":"e0181772","DOI":"10.1371\/journal.pone.0181772","volume":"12","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Chen T, Wang M, Jin L, Zhao Y, Chen S, Wang C, Zhang G, Wang Q, Deng Q, Liu Y, Morgan IG, He M, Liu Y, Congdon N (2017) Pilot study of a novel classroom designed to prevent myopia by increasing children\u2019s exposure to outdoor light. PLoS One 12:e0181772","journal-title":"PLoS One"},{"key":"1274_CR5","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","volume":"37","author":"MB Djamgoz","year":"1997","unstructured":"Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 37:3509\u20133529","journal-title":"Vision Res"},{"key":"1274_CR6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N (2018) Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson's disease pathology severity. Mov Disord 33:1315\u20131324","journal-title":"Mov Disord"},{"key":"1274_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.09.013","volume":"121","author":"N Mammadova","year":"2019","unstructured":"Mammadova N, Summers CM, Kokemuller RD, He Q, Ding S, Baron T, Yu C, Valentine RJ, Sakaguchi DS, Kanthasamy AG, Greenlee JJ (2019) Accelerated accumulation of retinal \u03b1-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease. Neurobiol Dis 121:1\u20136","journal-title":"Neurobiol Dis"},{"key":"1274_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","volume":"62","author":"C Funke","year":"2013","unstructured":"Funke C, Schneider SA, Berg D, Kell DB (2013) Genetics and iron in the systems biology of Parkinson's disease and some related disorders. Neurochem Int 62:637\u2013652","journal-title":"Neurochem Int"},{"key":"1274_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1444-0938.2007.00211.x","volume":"91","author":"RA Armstrong","year":"2008","unstructured":"Armstrong RA (2008) Visual signs and symptoms of Parkinson's disease. Clin Exp Optom 91:129\u2013138","journal-title":"Clin Exp Optom"},{"key":"1274_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JPD-140470","volume":"5","author":"TP Lin","year":"2015","unstructured":"Lin TP, Rigby H, Adler JS, Hentz JG, Balcer LJ, Galetta SL, Devick S, Cronin R, Adler CH (2015) Abnormal visual contrast acuity in Parkinson\u2019s disease. J Parkinsons Dis 5:125\u2013130","journal-title":"J Parkinsons Dis"},{"key":"1274_CR11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1468-1331.2010.03206.x","volume":"18","author":"YS Oh","year":"2011","unstructured":"Oh YS, Kim JS, Chung SW, Song IU, Kim YD, Kim YI, Lee KS (2011) Color vision in Parkinson\u2019s disease and essential tremor. Eur J Neurol 18:577\u2013583","journal-title":"Eur J Neurol"},{"key":"1274_CR12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","volume":"59","author":"NJ Diederich","year":"2002","unstructured":"Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol 59:1249\u20131252","journal-title":"Arch Neurol"},{"key":"1274_CR13","doi-asserted-by":"crossref","first-page":"e009658","DOI":"10.1136\/bmjopen-2015-009658","volume":"6","author":"V Polo","year":"2016","unstructured":"Polo V, Satue M, Rodrigo MJ, Otin S, Alarcia R, Bambo MP, Fuertes MI, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: an observational cross-sectional study. BMJ Open 6:e009658","journal-title":"BMJ Open"},{"key":"1274_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archneur.1979.00500420070009","volume":"36","author":"H Shibasaki","year":"1979","unstructured":"Shibasaki H, Tsuji S, Kuroiwa Y (1979) Oculomotor abnormalities in Parkinson\u2019s disease. Arch Neurol 36:360\u2013364","journal-title":"Arch Neurol"},{"key":"1274_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-12-5","volume":"12","author":"HP Elmar","year":"2012","unstructured":"Elmar HP, Reinhart J, Doroth\u00e9e L, Johanna H, Albert CL, Wolfgang B, Jan K (2012) Eye movement impairments in Parkinson\u2019s disease: possible role of extradopaminergic mechanisms. BMC Neurol 12:5","journal-title":"BMC Neurol"},{"key":"1274_CR16","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/npjparkd.2015.26","volume":"1","author":"SG Manohar","year":"2015","unstructured":"Manohar SG, Husain M (2015) Reduced pupillary reward sensitivity in Parkinson's disease. NPJ Parkinson\u2019s Dis 1:15026","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"1274_CR17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JPD-150686","volume":"5","author":"RA Armstrong","year":"2015","unstructured":"Armstrong RA (2015) Oculo-visual dysfunction in Parkinson\u2019s disease. J Parkinsons Dis 5:715\u2013726","journal-title":"J Parkinsons Dis"},{"key":"1274_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/bs.irn.2017.04.007","volume":"134","author":"RA Armstrong","year":"2017","unstructured":"Armstrong RA (2017) Visual dysfunction in Parkinson's disease. Int Rev Neurobiol 134:921\u2013946","journal-title":"Int Rev Neurobiol"},{"key":"1274_CR19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1460-9568.1997.tb01461.x","volume":"9","author":"ML Veruki","year":"1997","unstructured":"Veruki ML (1997) Dopaminergic neurons in the rat retina express dopamine D2\/3 receptors. Eur J Neurosci 9:1096\u20131100","journal-title":"Eur J Neurosci"},{"key":"1274_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J","volume":"418","author":"S He","year":"2000","unstructured":"He S, Weiler R, Vaney DI (2000) Endogenous dopaminergic regulation of horizontal cell coupling in the mammalian retina. J Comp Neurol 418:33\u201340","journal-title":"J Comp Neurol"},{"key":"1274_CR21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0952523804215127","volume":"21","author":"XB Xia","year":"2004","unstructured":"Xia XB, Mills SL (2004) Gap junctional regulatory mechanisms in the AII amacrine cell of the rabbit retina. Vis Neurosci 21:791\u2013805","journal-title":"Vis Neurosci"},{"key":"1274_CR22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuron.2008.07.017","volume":"59","author":"C Ribelayga","year":"2008","unstructured":"Ribelayga C, Cao Y, Mangel SC (2008) The circadian clock in the retina controls rod-cone coupling. Neuron 59:790\u2013801","journal-title":"Neuron"},{"key":"1274_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02307822","volume":"10","author":"J Nguyen-Legros","year":"1988","unstructured":"Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson\u2019s disease. Surg Radiol Anat 10:137\u2013144","journal-title":"Surg Radiol Anat"},{"key":"1274_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cne.20761","volume":"493","author":"N Cuenca","year":"2005","unstructured":"Cuenca N, Herrero MT, Angulo A, De Juan E, Mart\u0131nez- Navarrete GC, Lopez S, Barcia C, Mart\u00edn-Nieto J (2005) Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson\u2019s disease. J Comp Neurol 493:261\u2013273","journal-title":"J Comp Neurol"},{"key":"1274_CR25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jnnp.52.9.1033","volume":"52","author":"TJ Crawford","year":"1989","unstructured":"Crawford TJ, Goodrich S, Henderson L, Kennard C (1989) Predictive responses in PD: manual keypresses and saccadic eye movements to regular stimulus events. J Neurol Neurosurg Psychiatry 52:1033\u20131042","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1274_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuint.2006.08.001","volume":"50","author":"O Biehlmaier","year":"2007","unstructured":"Biehlmaier O, Alam M, Schmidt WJ (2007) A rat model of Parkinsonism shows depletion of dopamine in the retina. Neurochem Int 50:189\u2013195","journal-title":"Neurochem Int"},{"key":"1274_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.15283\/ijsc.2015.8.1.106","volume":"8","author":"I Ahmad","year":"2015","unstructured":"Ahmad I, Zhao X, Parameswaran S, Destache CJ, Rodriguez-Sierra J, Thoreson WB, Ahmad H, Sorrentino J, Balasubramanian S (2015) Direct differentiation of adult ocular progenitors into striatal dopaminergic neurons. Int J Stem Cells 8:106","journal-title":"Int J Stem Cells"},{"issue":"6","key":"1274_CR28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jnc.12475","volume":"128","author":"B Stutz","year":"2014","unstructured":"Stutz B, da Concei\u00e7\u00e3o FS, Santos LE, Cadilhe DV, Fleming RL, Acquarone M, Gardino PF, de Melo Reis RA, Dickson PW, Dunkley PR, Rehen S (2014) Murine dopaminergic M\u00fcller cells restore motor function in a model of Parkinson's disease. J Neurochem 128(6):829\u2013840","journal-title":"J Neurochem"},{"issue":"3","key":"1274_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0024-3205(88)90315-3","volume":"43","author":"F Ghilardi","year":"1988","unstructured":"Ghilardi F, Chung M, Bodis-Wollner E, Dvorzniak IM, Glover A, Onofrj M (1988) Systemic 1-methyl, 4-phenyl, 1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 43(3):255\u2013262","journal-title":"Life Sci"},{"issue":"7","key":"1274_CR30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0166-2236(90)90113-O","volume":"13","author":"I Bodis-Wollner","year":"1990","unstructured":"Bodis-Wollner I (1990) Visual deficits related to dopamine deficiency in experimental animals and Parkinson\u2019s disease patients. Trends Neurosci 13(7):296\u2013302","journal-title":"Trends Neurosci"},{"issue":"1","key":"1274_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-8993(90)91056-M","volume":"527","author":"WG Tatton","year":"1990","unstructured":"Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E (1990) MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res 527(1):21\u201331","journal-title":"Brain Res"},{"issue":"2","key":"1274_CR32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-4886(81)90092-3","volume":"71","author":"RS Dyer","year":"1981","unstructured":"Dyer RS, Howell WE, MacPhail RC (1981) Dopamine depletion slows retinal transmission. Exp Neurol 71(2):326\u2013340","journal-title":"Exp Neurol"},{"issue":"5","key":"1274_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ana.410110508","volume":"11","author":"M Onofrj","year":"1982","unstructured":"Onofrj M, Bodis-Wollner I (1982) Dopaminergic deficiency causes delayed visual evoked potentials in rats. Ann Neurol 11(5):484\u2013490","journal-title":"Ann Neurol"},{"key":"1274_CR34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/WNR.0b013e328354a1f0","volume":"23","author":"F Febbraro","year":"2012","unstructured":"Febbraro F, Giorgi M, Caldarola S, Loreni F, Romero-Ramos M (2012) Alpha-synuclein expression is modulated at the translational level by iron. NeuroReport 23:576\u2013580","journal-title":"NeuroReport"},{"key":"1274_CR35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/cn200074d","volume":"2","author":"Y Lu","year":"2011","unstructured":"Lu Y, Prudent M, Fauvet B, Lashuel HA, Girault HH (2011) Phosphorylation of alpha-synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of alpha-synuclein in the pathogenesis of Parkinson\u2019s disease and related disorders. ACS Chem Neurosci 2:667\u2013675","journal-title":"ACS Chem Neurosci"},{"key":"1274_CR36","doi-asserted-by":"crossref","first-page":"e15814","DOI":"10.1371\/journal.pone.0015814","volume":"6","author":"P Davies","year":"2011","unstructured":"Davies P, Moualla D, Brown DR (2011) Alpha-synuclein is a cellular ferrireductase. PLoS One 6:e15814","journal-title":"PLoS One"},{"key":"1274_CR37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/tx0497144","volume":"18","author":"I Paris","year":"2005","unstructured":"Paris I, Martinez-Alvarado P, Cardenas S, Perez-Pastene C, Graumann R, Fuentes P, Olea-Azar C, Caviedes P, Segura-Aguilar J (2005) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol 18:415\u2013419","journal-title":"Chem Res Toxicol"},{"key":"1274_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-017-0186-8","volume":"12","author":"JA Duce","year":"2017","unstructured":"Duce JA, Wong BX, Durham H, Devedjian JC, Smith DP, Devos D (2017) Post translational changes to \u03b1-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson\u2019s disease. Mol Neurodegener 12:45","journal-title":"Mol Neurodegener"},{"key":"1274_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00059","volume":"9","author":"S Gallegos","year":"2015","unstructured":"Gallegos S, Pacheco C, Peters C, Opazo C, Aguayo LG (2015) Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson\u2019s disease. Front Neurosci 9:1\u201311","journal-title":"Front Neurosci"},{"key":"1274_CR40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurol 3:932\u2013942","journal-title":"Nat Rev Neurol"},{"key":"1274_CR41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-130306","volume":"4","author":"JY Lee","year":"2014","unstructured":"Lee JY, Ahn J, Kim TW, Jeon BS (2014) Optical coherence tomography in Parkinson's disease: is the retina a biomarker? J Parkinson's Dis 4:197\u2013204","journal-title":"J Parkinson's Dis"},{"key":"1274_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mds.25741","volume":"29","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Miri S, Glazman S (2014) Venturing into the no-man\u2019s land of the retina in Parkinson\u2019s disease. Mov Disord 29:15\u201322","journal-title":"Mov Disord"},{"key":"1274_CR43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci Lett 571:34\u201338","journal-title":"Neurosci Lett"},{"key":"1274_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jnr.1129","volume":"65","author":"A Surguchov","year":"2001","unstructured":"Surguchov A, McMahan B, Masliah E, Surgucheva I (2001) Synucleins in ocular tissues. J Neurosci Res 65:68\u201377","journal-title":"J Neurosci Res"},{"key":"1274_CR45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123:383\u2013396","journal-title":"Cell"},{"key":"1274_CR46","first-page":"1","volume":"5","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortu\u00f1o-Lizar\u00e1n I, Baekelandt V, Cuenca N, Moons L, De Groef L (2019) Retinal \u03b1-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol 5:1\u20137","journal-title":"Acta Neuropathol"},{"key":"1274_CR47","first-page":"949","volume":"13","author":"GC Mart\u0131nez-Navarrete","year":"2007","unstructured":"Mart\u0131nez-Navarrete GC, Mart\u0131n-Nieto J, Esteve RJ, Angulo A, Cuenca N (2007) Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis 13:949\u2013961","journal-title":"Mol Vis"},{"key":"1274_CR48","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) \u03b1-Synuclein in the inner retina in Parkinson disease. Ann Neurol 75:964\u2013966","journal-title":"Ann Neurol"},{"key":"1274_CR49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12264-017-0174-6","volume":"33","author":"W Le","year":"2017","unstructured":"Le W, Dong J, Li S, Korczyn AD (2017) Can biomarkers help the early diagnosis of Parkinson\u2019s disease? Neurosci Bull 33:535\u2013542","journal-title":"Neurosci Bull"},{"key":"1274_CR50","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR (2016) Visual dysfunction in Parkinson\u2019s disease. Brain 139:2827\u20132843","journal-title":"Brain"},{"key":"1274_CR51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","volume":"43","author":"N Cuenca","year":"2014","unstructured":"Cuenca N, Fernandez-Sanchez L, Campello L, Maneu V, De la Villa P, Lax P, Pinilla I (2014) Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res 43:17\u201375","journal-title":"Prog Retin Eye Res"},{"key":"1274_CR52","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.parkreldis.2015.09.015","volume":"22","author":"S Miri","year":"2016","unstructured":"Miri S, Glazman S, Mylin L, Bodis-Wollner I (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson\u2019s disease. Parkinsonism Relat Disord 22:S134\u2013S137","journal-title":"Parkinsonism Relat Disord"},{"key":"1274_CR53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD). Doc Ophthalmol 131:95\u2013104","journal-title":"Doc Ophthalmol"},{"key":"1274_CR54","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","volume":"44","author":"R Inzelberg","year":"2004","unstructured":"Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793\u20132797","journal-title":"Vis Res"},{"key":"1274_CR55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/WNO.0b013e3182701745","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S, Turkyilmaz K, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 33:62\u201365","journal-title":"J Neuroophthalmol"},{"key":"1274_CR56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","volume":"20","author":"C La Morgia","year":"2013","unstructured":"La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra BG, Liguori R (2013) Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20:198\u2013201","journal-title":"Eur J Neurol"},{"key":"1274_CR57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","volume":"116","author":"O Altintas","year":"2008","unstructured":"Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease. Doc Ophthalmol 116:137\u2013146","journal-title":"Doc Ophthalmol"},{"key":"1274_CR58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-121975","volume":"34","author":"T Moreno-Ramos","year":"2013","unstructured":"Moreno-Ramos T, Benito-Le\u00b4on J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson\u2019s disease, dementia with Lewy bodies, and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 34:659\u2013694","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1274_CR59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/IAE.0000000000000028","volume":"34","author":"E Garcia-Martin","year":"2013","unstructured":"Garcia-Martin E, Satue M, Otin S, Fuertes I, Alarcia R, Larrosa JM, Polo V, Pablo LE (2013) Retina measurements for diagnosis of Parkinson disease. Retina 34:971\u2013980","journal-title":"Retina"},{"key":"1274_CR60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2013.4","volume":"27","author":"M Satue","year":"2013","unstructured":"Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, Bambo MP, Pablo LE, Fernandez FJ (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients. Eye 27:507\u2013514","journal-title":"Eye"},{"key":"1274_CR61","doi-asserted-by":"crossref","first-page":"e34891","DOI":"10.1371\/journal.pone.0034891","volume":"7","author":"P Albrecht","year":"2012","unstructured":"Albrecht P, Muller AK, Sudmeyer M, Ferrea S, Ringelstein M, Cohn E, Aktas O, Dietlein T, Lappas A, Foerster A, Hartung HP, Schnitzler A, Methner A (2012) Optical coherence tomography in Parkinsonian syndromes. PLoS One 7:e34891","journal-title":"PLoS One"},{"key":"1274_CR62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00702-013-1093-y","volume":"121","author":"E Cubo","year":"2014","unstructured":"Cubo E, L\u00b4opez Pe\u02dcna MJ, Diez-Feijo VE, P\u00b4erez GO, Garcia GP, Araus GE, Prieto TR, Mariscal PN, Armesto D (2014) Lack of association of morphologic and functional retinal changes with motor and non-motor symptoms severity in Parkinson\u2019s disease. J Neural Transm 121:139\u2013145","journal-title":"J Neural Transm"},{"key":"1274_CR63","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ophtha.2012.05.003","volume":"119","author":"E Garcia-Martin","year":"2012","unstructured":"Garcia-Martin E, Satue M, Fuertes I, Otin S, Alarcia R, Herrero R, Bambo MP, Fernandez J, Pablo LE (2012) Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson\u2019s disease. Ophthalmology 119:2161\u20132167","journal-title":"Ophthalmology"},{"key":"1274_CR64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JPD-171184","volume":"8","author":"LJ Ma","year":"2018","unstructured":"Ma LJ, Xu LL, Mao CJ, Fu YT, Ji XY, Shen Y, Chen J, Yang YP, Liu CF (2018) progressive changes in the retinal structure of patients with Parkinson\u2019s disease. J Parkinson's Dis 8:85\u201392","journal-title":"J Parkinson\u2019s Dis"},{"key":"1274_CR65","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1167\/iovs.16-20460","volume":"58","author":"M Satue","year":"2017","unstructured":"Satue M, Rodrigo MJ, Obis J, Vilades E, Gracia H, Otin S, Fuertes MI, Alarcia R, Crespo JA, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2017) Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson\u2019s disease. Investig Ophthalmol Vis Sci 58:1151\u20131157","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1274_CR66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","volume":"157","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157:470\u2013478","journal-title":"Am J Ophthalmol"},{"key":"1274_CR67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00702-013-1072-3","volume":"121","author":"M Schneider","year":"2014","unstructured":"Schneider M, M\u00a8uller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH (2014) Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm 121:41\u201347","journal-title":"J Neural Transm"},{"key":"1274_CR68","first-page":"728457","volume":"2012","author":"EM Schrier","year":"2012","unstructured":"Schrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I (2012) Interocular asymmetry of foveal thickness in Parkinson\u2019s disease. J Ophthalmol 2012:728457","journal-title":"J Ophthalmol"},{"key":"1274_CR69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"ME Hajee","year":"2009","unstructured":"Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG (2009) Inner retinal layer thinning in Parkinson\u2019s disease. Arch Ophthalmol 127:737\u2013741","journal-title":"Arch Ophthalmol"},{"key":"1274_CR70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","volume":"33","author":"CR Adam","year":"2013","unstructured":"Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137\u2013142","journal-title":"J Neuroophthalmol"},{"key":"1274_CR71","first-page":"1427","volume":"4","author":"GD Aaker","year":"2010","unstructured":"Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S (2010) Detection of retinal changes in Parkinson\u2019s disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427\u20131432","journal-title":"Clin Ophthalmol"},{"key":"1274_CR72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","volume":"4","author":"EM Normando","year":"2016","unstructured":"Normando EM, Davis BM, De Groef L, Nizari S, Turner LA, Ravindran N, Pahlitzsch M, Brenton J, Malaguarnera G, Guo L, Somavarapu S (2016) The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol Commun 4:86","journal-title":"Acta Neuropathol Commun"},{"key":"1274_CR73","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1038\/cddis.2009.3","volume":"1","author":"MF Cordeiro","year":"2010","unstructured":"Cordeiro MF, Guo L, Coxon KM, Duggan J, Nizari S, Normando EM, Sensi SL, Sillito AM, Fitzke FW, Salt TE, Moss SE (2010) Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis 1:e3","journal-title":"Cell Death Dis"},{"key":"1274_CR74","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1167\/iovs.17-23230","volume":"59","author":"WR Kwapong","year":"2018","unstructured":"Kwapong WR, Ye H, Peng C, Zhuang X, Wang J, Shen M, Lu F (2018) Retinal microvascular impairment in the early stages of Parkinson's disease. Investig Ophthalmol Vis Sci 59:4115\u20134122","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1274_CR75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","volume":"355","author":"J Chorostecki","year":"2015","unstructured":"Chorostecki J, Seraji-Bozorgzad N, Shah A, Bao F, Bao G, George E, Gorden V, Caon C, Frohman E, Bhatti MT, Khan O (2015) Characterization of retinal architecture in Parkinson's disease. J Neurol Sci 355:44\u201348","journal-title":"J Neurol Sci"},{"key":"1274_CR76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1167\/iovs.13-13062","volume":"55","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Rodriguez-Mena D, Satue M, Almarcegui C, Dolz I, Alarcia R, Seral M, Polo V, Larrosa JM, Pablo LE (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Investig Ophthalmol Vis Sci 55:696\u2013705","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1274_CR77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s004150170051","volume":"248","author":"O Vesel\u00e1","year":"2001","unstructured":"Vesel\u00e1 O, R\u016f\u017ei\u010dka E, Jech R, Roth J, \u0160t\u011bp\u00e1nkov\u00e1 K, Me\u010d\u00ed\u0159 P, Solano Z, Precl\u00edkov\u00e1 E (2001) Colour discrimination impairment is not a reliable early marker of Parkinson's disease. J Neurol 248:975\u2013978","journal-title":"J Neurol"},{"key":"1274_CR78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2047-783X-19-29","volume":"19","author":"L Sun","year":"2014","unstructured":"Sun L, Zhang H, Gu ZQ, Cao M, Li DW, Chan P (2014) Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson\u2019s disease. Eur J Med Res 19:29","journal-title":"Eur J Med Res"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-020-01274-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T01:13:10Z","timestamp":1611105190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-020-01274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01274-w","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SMD, IM, APN, DV and VB declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article; thus, it does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This is a review article; thus it does not need any consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}